Insider trading

Period: 12 months Plan: Discretionary × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

36,752 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

36,752 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

36,752 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

36,752 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
36,752 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
36,752 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

36,752 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
20 Jan 2026
ASHER DANIEL 10% owner · indirect
Bought
$104.08K 19,660 at 5.29
1.1%
20 Jan 2026
Dietze Jane A Director
Bought
$99.49K 1,000 at 99.49
38.5%
+38% of stake
20 Jan 2026
de los Pinos Elisabet See Remarks
Sold at will
$82.27K 16,928 at 4.86
3.6%
Not planned
20 Jan 2026
Trigg Leslie Chair and CEO
Sold at will
$60.39K 11,794 at 5.12
9.9%
Not planned
20 Jan 2026
Ugwumba Chidozie 10% owner · indirect
Sold at will
$59.67K 12,432 at 4.80
1.9%
Not planned
20 Jan 2026
Brottem John L. General Counsel
Sold at will
$47.69K 9,314 at 5.12
20.1%
Not planned
20 Jan 2026
Sold at will
$36.33K 6,522 at 5.57
0.7%
Not planned
20 Jan 2026
Harris Jonathan President and CEO
Sold at will
$30.81K 2,311 at 13.33
0.9%
Not planned
20 Jan 2026
Nash Marc EVP Operations R&D & Service
Sold at will
$27.52K 5,375 at 5.12
11.2%
Not planned
20 Jan 2026
Bought
$22.00K 444 at 49.58
8.7%
Largest buy in 3 yrs
20 Jan 2026
Bought
$20.00K 403 at 49.58
10.7%
First buy on file
20 Jan 2026
Bought
$15.00K 303 at 49.58
3.2%
Largest buy in 3 yrs
20 Jan 2026
SCHORSCH NICHOLAS S 10% owner · indirect
Bought
$14.40K 1,365 at 10.55
0.1%
20 Jan 2026
Opperman Sarah R Director
Bought
$13.75K 277 at 49.58
1.1%
Largest buy in 3 yrs
20 Jan 2026
Sold at will
$13.58K 10,000 at 1.36
0.4%
Not planned
20 Jan 2026
Bourland Jill Director
Bought
$12.00K 242 at 49.58
4.3%
20 Jan 2026
Bought
$12.00K 242 at 49.58
65.6%
Largest buy in 3 yrs
20 Jan 2026
Evans Jae A Director
Bought
$9.97K 201 at 49.58
0.8%
20 Jan 2026
Coen Steven P. See remarks
Sold at will
$8.67K 972 at 8.92
10.5%
Not planned
20 Jan 2026
Elazzouzi Amy Senior Vice President, Finance
Sold at will
$7.68K 1,581 at 4.86
1.8%
Not planned
20 Jan 2026
Gleason Shane Thomas Chief Commercial Officer
Sold at will
$4.71K 2,955 at 1.59
0.2%
Not planned
20 Jan 2026
Dizon Romeo R Chief Financial Officer
Bought
$3.15K 2,100 at 1.50
2.2%
20 Jan 2026
Crawford Amanda Chief Financial Officer
Sold at will
$2.44K 183 at 13.33
0.1%
Not planned
20 Jan 2026
STAHL MURRAY President/Co-Portfolio Manager · indirect
Bought 6×
$2.08K 774 at 2.69
0.2%
20 Jan 2026
Bought
$1.21K 300 at 4.04
0.0%
20 Jan 2026
STAHL MURRAY President/Co-Portfolio Manager
Bought
$968.40 360 at 2.69
0.3%
20 Jan 2026
Altman Peter President and CEO
Bought
$792.00 600 at 1.32
0.2%
20 Jan 2026
Bought
$334.13 1 at 334.13
0.0%
20 Jan 2026
Peterson Scott Edward Chief Financial Officer · indirect
Bought
$0.00 11,593 at 0.00
13.7%
First buy on file
16 Jan 2026
VINIAR DAVID A Director
Sold at will 18×
$43.44M 45,000 at 965.33
7.5%
Not planned
16 Jan 2026
Small Martin CFO & Senior Managing Director
Sold at will 4×
$31.68M 27,047 at 1,171.14
71.9%
Sold half or more
16 Jan 2026
VINIAR DAVID A Director · indirect
Sold at will 19×
$22.38M 23,186 at 965.27
18.8%
Not planned
16 Jan 2026
Smith Richard Craig Sr. Vice President
Sold at will
$11.17M 3,190 at 3,500.00
54.8%
Sold half or more
16 Jan 2026
Sun Kang Director
Sold at will
$10.52M 950,548 at 11.07
40.4%
Not planned
16 Jan 2026
WATSA V PREM ET AL 10% owner · indirect
Bought
$10.28M 1,837,686 at 5.60
19.4%
16 Jan 2026
Cummins Wes CEO; Chairman
Sold at will
$6.01M 165,000 at 36.42
3.8%
Not planned
16 Jan 2026
MONDELLO MARK T Executive Chairman
Sold at will 2×
$4.30M 17,200 at 250.00
1.5%
Not planned
16 Jan 2026
Sold at will
$4.19M 11,044 at 379.15
18.1%
Not planned
16 Jan 2026
Bought
$4.01M 324,295 at 12.37
3.7%
16 Jan 2026
Sold at will
$3.31M 734,747 at 4.50
28.3%
Not planned
16 Jan 2026
Monia Brett P Chief Executive Officer
Sold at will
$3.29M 44,034 at 74.82
16.4%
Not planned
16 Jan 2026
Snell Erik Storey EVP & Chief Cust Exper Officer
Sold at will
$2.80M 39,420 at 71.02
52.5%
Sold half or more
16 Jan 2026
Saba Capital Management, L.P. 10% owner · indirect
Sold at will
$1.20M 75,435 at 15.94
0.3%
Not planned
16 Jan 2026
Sold at will
$1.00M 2,860 at 350.00
16.2%
Not planned
16 Jan 2026
HOUGEN ELIZABETH L EVP, Finance & CFO
Sold at will
$971.99K 12,922 at 75.22
9.3%
Not planned
16 Jan 2026
BERKOWITZ BRUCE R 10% owner
Sold at will
$910.45K 13,900 at 65.50
0.1%
Not planned
16 Jan 2026
Swayze Eric EVP Research
Sold at will
$744.66K 9,884 at 75.34
19.1%
Not planned
16 Jan 2026
Schneider Eugene EVP, Chf Clinical Develop Ofcr
Sold at will
$703.14K 9,302 at 75.59
12.7%
Not planned
16 Jan 2026
O'NEIL PATRICK R. EVP CLO & General Counsel
Sold at will
$697.05K 9,191 at 75.84
12.2%
Not planned
16 Jan 2026
BENNETT C FRANK EVP, Chief Scientific Officer
Sold at will
$674.62K 8,977 at 75.15
8.7%
Not planned
Showing 27,951–28,000 of 36,752. ← Newer Page 560 of 736 Older →